Marzena S.
- Country
- Poland
- Department
- NZOZ Neuro-Kard Ilkowski I Partnerzy sp.p. Lekarzy
Research Overview
- Evaluation of ODM-111 Efficacy and Tolerability in Chronic Pain Management for Diabetic Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Trial
- Evaluation of LY3556050 in a Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Phase 2 Study for Diabetic Peripheral Neuropathic Pain in Adults
- Phase 3 Randomized Double-Blind Trial Comparing Efficacy and Safety of Retatrutide (LY3437943) Versus Tirzepatide (LY3298176) in Adults with Obesity
Data & Insights
Has run more than one trial at 15 of 82 partner sites.
Specializations
Metabolic Health
This investigator specializes in treating obesity through innovative therapeutic approaches, exploring advanced treatment options for weight management and metabolic disorders.
- Weight Management Interventions
- Metabolic Treatment Evaluation
- Comparative Therapy Assessment
The research focus includes evaluating novel therapeutic agents for obesity treatment and their comparative effectiveness.
Pain Management
The investigator conducts research in diabetic peripheral neuropathic pain management, with particular attention to innovative treatment modalities including medical cannabis applications.
- Neuropathic Pain Treatment
- Medical Cannabis Research
- Pain Intensity Assessment
Their work encompasses the evaluation of various therapeutic approaches for managing chronic neuropathic pain conditions.
Chronic Pain Therapy
Specialized research in chronic pain due to diabetic peripheral neuropathy, focusing on evaluating novel therapeutic interventions for long-term pain management.
- DPN Pain Management
- Novel Treatment Evaluation
- Chronic Pain Therapeutics
The investigator examines innovative therapeutic solutions for chronic neuropathic pain conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.